ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 4, Pages 802
Publisher
MDPI AG
Online
2020-04-01
DOI
10.3390/cancers12040802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantitative Measurement of Functional Activity of the PI3K Signaling Pathway in Cancer
- (2019) Anja van de Stolpe Cancers
- Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types
- (2019) Anja van de Stolpe et al. Scientific Reports
- Estrogen Receptor pathway activity score to predict clinical response or resistance to neo-adjuvant endocrine therapy in primary breast cancer
- (2019) Marcia A. Inda et al. MOLECULAR CANCER THERAPEUTICS
- Assessment of Functional Phosphatidylinositol 3-Kinase Pathway Activity in Cancer Tissue Using Forkhead Box O Target Gene Expression in a Knowledge-Based Computational Model
- (2018) Henk van Ooijen et al. AMERICAN JOURNAL OF PATHOLOGY
- FOXO Transcription Factors Both Suppress and Support Breast Cancer Progression
- (2018) Marten Hornsveld et al. CANCER RESEARCH
- Phosphoinositide 3-Kinase/Akt Signaling and Redox Metabolism in Cancer
- (2018) Nikos Koundouros et al. Frontiers in Oncology
- A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer
- (2017) Momeneh Foroutan et al. MOLECULAR CANCER RESEARCH
- MYC Is a Crucial Mediator of TGF -Induced Invasion in Basal Breast Cancer
- (2016) M. A. Cichon et al. CANCER RESEARCH
- Chronic oxidative stress promotes H2AX protein degradation and enhances chemosensitivity in breast cancer patients
- (2016) Tina Gruosso et al. EMBO Molecular Medicine
- Prediction of Trastuzumab Benefit in HER2-Positive Breast Cancers: Is It in the Intrinsic Subtype?
- (2016) Jisun Kim et al. JNCI-Journal of the National Cancer Institute
- Signaling Cross Talk between TGF-β/Smad and Other Signaling Pathways
- (2016) Kunxin Luo Cold Spring Harbor Perspectives in Biology
- Prediction of Trastuzumab Benefit in HER2-Positive Breast Cancers: Is It in the Intrinsic Subtype?
- (2016) Jisun Kim et al. JNCI-Journal of the National Cancer Institute
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) E. Senkus et al. ANNALS OF ONCOLOGY
- Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort
- (2015) K. Elebro et al. CLINICAL CANCER RESEARCH
- TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
- (2015) M-F Pang et al. ONCOGENE
- Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways
- (2014) W. Verhaegh et al. CANCER RESEARCH
- Complexities of androgen receptor signalling in breast cancer
- (2014) Keely M McNamara et al. ENDOCRINE-RELATED CANCER
- Picking the Point of Inhibition: A Comparative Review of PI3K/AKT/mTOR Pathway Inhibitors
- (2014) R. Dienstmann et al. MOLECULAR CANCER THERAPEUTICS
- Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer
- (2013) Rosalind Brigham Penney et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Hotspot mutations in PIK3CA associate with first-line treatment outcome for aromatase inhibitors but not for tamoxifen
- (2013) Diana E. Ramirez-Ardila et al. BREAST CANCER RESEARCH AND TREATMENT
- Role of hypoxia-inducible factors in breast cancer metastasis
- (2013) Daniele M Gilkes et al. Future Oncology
- FOXOs: signalling integrators for homeostasis maintenance
- (2013) Astrid Eijkelenboom et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The FoxO–BNIP3 axis exerts a unique regulation of mTORC1 and cell survival under energy stress
- (2013) A Lin et al. ONCOGENE
- Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
- (2013) Anna Babayan et al. PLoS One
- Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use
- (2011) A. van de Stolpe et al. CANCER RESEARCH
- Frozen robust multiarray analysis (fRMA)
- (2010) M. N. McCall et al. BIOSTATISTICS
- Relevance of BCAR4 in tamoxifen resistance and tumour aggressiveness of human breast cancer
- (2010) M F E Godinho et al. BRITISH JOURNAL OF CANCER
- Crosstalk of reactive oxygen species and NF-κB signaling
- (2010) Michael J Morgan et al. CELL RESEARCH
- PIK3CA Mutations May Be Discordant between Primary and Corresponding Metastatic Disease in Breast Cancer
- (2010) J. Dupont Jensen et al. CLINICAL CANCER RESEARCH
- Intratumor Heterogeneity and Precision of Microarray-Based Predictors of Breast Cancer Biology and Clinical Outcome
- (2010) William T. Barry et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
- (2009) Francesca De Amicis et al. BREAST CANCER RESEARCH AND TREATMENT
- Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis
- (2009) Nikolas H. Stoecklein et al. INTERNATIONAL JOURNAL OF CANCER
- Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
- (2009) C. J. Creighton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Roles of TGFβ in metastasis
- (2008) David Padua et al. CELL RESEARCH
- Relevance of Breast Cancer Antiestrogen Resistance Genes in Human Breast Cancer Progression and Tamoxifen Resistance
- (2008) Ton van Agthoven et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now